Prokidney to participate in the ubs virtual organ restoration day

Winston-salem, n.c., oct. 09, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the ubs virtual organ restoration day, which will be taking place on october 15, 2024.
PROK Ratings Summary
PROK Quant Ranking